Please assess the completion status of the following clinical trial:

Trial Title: Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* symptomatic NYHA II or III chronic heart failure~* left ventricular systolic dysfunction~* moderate or severe chronic obstructive pulmonary disease~* with or without significant reversibility~Exclusion Criteria:~* beta-blocker contraindications~* non-dihydropyridine (diltiazem / verapamil) calcium channel blockers~* recent coronary percutaneous intervention or coronary artery bypass graft surgery~* haemodynamically significant valvular disease or hypertrophic cardiomyopathy.~* active myocarditis or pericarditis.~* recent cerebrovascular accident or transient ischaemic attack~* serious concurrent systemic disease, such as malignancy, resulting in likely reduced life expectancy~* pregnancy, childbearing potential with inadequate contraception, breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Bisoprolol
- 2 (Type: PLACEBO_COMPARATOR): Identical appearance matching placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).